Stroke Journal
JANUARY 30, 2025
The exposure was a new diagnosis of non-traumatic intracranial hemorrhage, defined as a composite of intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and subdural hemorrhage (SDH). In secondary analyses, the risks of dementia in different subtypes of intracranial hemorrhage were studied.Results:Among 2.1
Stroke Journal
JANUARY 30, 2025
Introduction:Alzheimers Disease (AD), characterized by extracellular deposition of amyloid beta (A) plaques in brain tissue, is often comorbid with cerebral amyloid angiopathy, which carries an elevated risk of intracranial hemorrhage. The exposure variable was AD, defined byICD-9-CMcode 331.0 andICD-10-CMcode G30.x.
Stroke Journal
JANUARY 30, 2025
The exposure was an incident diagnosis of non-traumatic intracranial hemorrhage, defined as a composite of intracerebral hemorrhage, subarachnoid hemorrhage, or subdural hemorrhage. In secondary analyses, the risks of dementia in different subtypes of intracranial hemorrhage were studied.Results:Among 2.1
Stroke Journal
JANUARY 30, 2025
The study outcome was a new speech pathology (SLT), occupational therapy (OT), or physical therapy (PT) encounter during the first year after discharge.Results:57,647 total cases were identified with 30% Medicare FFS, 33% Truven (Commercial) Medicare Advantage plan (65 years and older), and 37% Truven commercial (less than 65 years old).
Stroke Journal
JANUARY 30, 2025
Patients with a history of primary intracerebral hemorrhage or subarachnoid hemorrhage at baseline were classified as ruptured AVM (rAVM) patients. Medicare) patients (1.82, 1.45 2.26) had higher odds of receiving surgical AVM treatment (Table 1). NHW) patients (1.76, 1.20 2.58) and privately insured (vs.
Stroke Journal
JANUARY 30, 2025
Medicare, 1.17 [1.08-1.26]; Across both IR discharge models, patients who were male (aORs: 1.17 [1.08-1.26]; 1.26]; 1.30 [1.18-1.43]), 1.43]), [FV2] had a history of antihypertensive use (1.18 [1.04-1.34]; 1.34]; 1.27 [1.08-1.51]), 1.51]), and received EVT (2.02 [1.70-2.40]; 2.40]; 2.05 [1.70-2.46]) home or UD) (Figure 1). 1.26]; 1.30 [1.18-1.43])
Stroke Journal
JANUARY 30, 2025
There are limited population-based data regarding the prevalence of CAA and associated risks of mortality and incident cerebrovascular events.Methods:We performed a retrospective cohort study using inpatient and outpatient claims from 2008 to 2018 from a nationally representative 5% sample of Medicare beneficiaries. 95% CI, 19.6-52.4),
Expert insights. Personalized for you.
40 
Let's personalize your content